Turkey – Celltrion’s ‘Remsima’ receives Turkey MOH approval

July 18, 2014 2:03 pm0 comments
Source : Google

Turkey is the world’s 16th largest pharmaceutical market with a TNF-α inhibitor treatment market size of approximately USD 150 million. Celltrion is expected to market Remsima within the fourth quarter of this year with partner company Mustafa Nevzat. Celltrion announced today that the Ministry of Health in Turkey (MoH) has […]

Read more ›

Egypt – Abraaj Group to make 97 m US$ bid to acquire Amoun Pharmaceuticals

July 17, 2014 4:14 pm0 comments
Egypt – Abraaj Group to make 97 m US$ bid to acquire Amoun Pharmaceuticals

Investment company Abraaj Group plans to issue a purchase offer to Amoun Pharmaceuticals Company with a value averaging between EGP700m and EGP800m, Mubasher News reported Tuesday. Abraaj Group announced Sunday that it also intends to acquire up to 100% of the shares of confectionary company Bisco Misr Company through issuing […]

Read more ›

Israël – Vascular Biogenics sets terms for $76 million IPO

4:01 pm0 comments
Israël – Vascular Biogenics sets terms for $76 million IPO

Vascular Biogenics, a biotech developing gene therapies for certain cancers and inflammatory diseases, announced terms for its IPO on Wednesday. The Or Yehuda, Israel-based company plans to raise $76 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, […]

Read more ›

Iran – Official : “Iran Producing 4 High-Quality Nano Drugs”

3:21 pm0 comments
Iran – Official : “Iran Producing 4 High-Quality Nano Drugs”

Iran is now producing 4 nano drugs, mostly for cancer patients, which enjoy higher quality than the foreign products and at a lower cost, an official announced on Wednesday. “At present, 4 nano drugs are being produced and presented (to the market),” Hossein Shakki, the director of the Iran Nanotechnology […]

Read more ›

Egypt – MOH closes deal with Gilead Sciences for Hepatitis C drug at 99% discount

9:16 am0 comments
Egypt – MOH closes deal with Gilead Sciences for Hepatitis C drug at 99% discount

The Ministry of Health signed a memorandum of understanding (MOU) with American pharmaceutical company Gilead Sciences to supply the company’s hepatitis C treatment Sovaldi at 1% of its original price, Minister of Health Adel Al-Adawy said. The health minister added that the cost of a 3-month treatment of Sovaldi abroad […]

Read more ›

Israël – FDA accepts Teva’s NDA for albuterol MDPI

July 16, 2014 3:43 pm0 comments
Israël – FDA accepts Teva’s NDA for albuterol MDPI

Israel-based generic giant Teva Pharmaceuticals Industries (NYSE: TEVA) says that the US Food and Drug Administration has accepted for review the company’s New Drug Application for albuterol multi-dose dry-powder inhaler (MDPI). This is an investigational breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of […]

Read more ›

Jordan – Hikma Pharmaceuticals acquires Bedford Laboratories

3:27 pm0 comments
Jordan – Hikma Pharmaceuticals acquires Bedford Laboratories

London, 15 July 2014 – Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces that it has completed its acquisition of assets of the US generic injectables business, Bedford Laboratories (“Bedford”) from Ben Venue Laboratories, Inc., a member of the […]

Read more ›

Turkey – Country aims to become ‘global player’ in biopharma

June 27, 2014 6:06 pm0 comments
Source : Google

Turkey’s government has pledged to make it easier to register new drugs and will boost the country’s research base with the formation of a series of publicly-funded national health institutes. The initiatives – revealed by minister of development Cevdet Yılmaz – are part of a strategic plan to make Turkey […]

Read more ›

Israël – Chinese Fosun Pharma buys Alma Lasers for 240 million $

May 9, 2013 10:21 am0 comments
Israël – Chinese Fosun Pharma buys Alma Lasers for 240 million $

The Chinese Shanghai Fosun Pharmaceutical Group will acquire 95.6% of the shares in the Israeli group Alma Lasers specialized in solutions for cosmetic laser treatments, for  240 million $ . Alma Lasers, led by Dr. Tzvi Karmi, has a 15% share of the global market for aesthetic high-end devices with […]

Read more ›

Turkey – Government planning special Pharma zones

February 12, 2013 1:09 pm0 comments
Turkey – Government planning special Pharma zones

Turkey’s growing pharmaceutical sector, holding immense potential for foreign drug producers thanks to the increasing availability of high quality healthcare for all segments of the country’s large population, will soon have special industry zones that focus on the research, development and production of drugs. According to a strategy document in […]

Read more ›

Recent Comments

    Tags